Found: 26
Select item for more details and to access through your institution.
Real‐life effectiveness of iGlarLixi (insulin glargine 100 U/mL and lixisenatide) in people with type 2 diabetes according to prior insulin use.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 7, p. 2988, doi. 10.1111/dom.15609
- By:
- Publication type:
- Article
iGlarLixi (insulin glargine 100 U/ml plus lixisenatide) is effective and well tolerated in people with uncontrolled type 2 diabetes regardless of age: A REALI pooled analysis of prospective real‐world data.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1723, doi. 10.1111/dom.15027
- By:
- Publication type:
- Article
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin‐treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 6, p. 1221, doi. 10.1111/dom.14354
- By:
- Publication type:
- Article
Take Control: A randomized trial evaluating the efficacy and safety of self‐ versus physician‐managed titration of insulin glargine 300 U/mL in patients with uncontrolled type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 7, p. 1615, doi. 10.1111/dom.13697
- By:
- Publication type:
- Article
Glycaemic control and hypoglycaemia benefits with insulin glargine 300 U/mL extend to people with type 2 diabetes and mild‐to‐moderate renal impairment.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 12, p. 2860, doi. 10.1111/dom.13470
- By:
- Publication type:
- Article
Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 2, p. 301, doi. 10.1111/dom.13064
- By:
- Publication type:
- Article
The IDEAL (Insulin therapy DE-intensificAtion with iglarLixi) Randomised Controlled Trial—Study Design and Protocol.
- Published in:
- Diabetes Therapy, 2024, v. 15, n. 6, p. 1461, doi. 10.1007/s13300-024-01582-x
- By:
- Publication type:
- Article
Effectiveness and Safety of iGlarLixi (Insulin Glargine 100 U/mL Plus Lixisenatide) in Type 2 Diabetes According to the Timing of Daily Administration: Data from the REALI Pooled Analysis.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 4, p. 639, doi. 10.1007/s13300-023-01375-8
- By:
- Publication type:
- Article
Glycaemic Control in People with Type 2 Diabetes Mellitus Switching from Basal Insulin to Insulin Glargine 300 U/ml (Gla-300): Results from the REALI Pooled Database.
- Published in:
- Diabetes Therapy, 2023, v. 14, n. 2, p. 401, doi. 10.1007/s13300-022-01356-3
- By:
- Publication type:
- Article
Does Gender Influence the Effectiveness and Safety of Insulin Glargine 300 U/ml in Patients with Uncontrolled Type 2 Diabetes? Results from the REALI European Pooled Analysis.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 1, p. 57, doi. 10.1007/s13300-021-01179-8
- By:
- Publication type:
- Article
Glycaemic Control with Insulin Glargine 300 U/mL in Individuals with Type 2 Diabetes and Chronic Kidney Disease: A REALI European Pooled Data Analysis.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1159, doi. 10.1007/s13300-021-01031-z
- By:
- Publication type:
- Article
Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis.
- Published in:
- Diabetes Therapy, 2021, v. 12, n. 4, p. 1073, doi. 10.1007/s13300-021-01030-0
- By:
- Publication type:
- Article
234-OR: Advancing Therapy in Uncontrolled Basal Insulin-Treated Type 2 Diabetes (T2D): Better Clinical Outcomes with IGlarLixi vs. Premix 70/30 in the SoliMix Trial.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-234-OR
- By:
- Publication type:
- Article
748-P: Advancing Therapy in Uncontrolled Basal Insulin (BI)-Treated Type 2 Diabetes (T2D): Subanalysis of the SoliMix Trial in Participants in Europe.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-748-P
- By:
- Publication type:
- Article
724-P: Factors Associated with Glycemic Control in People with Type 1 Diabetes (PWT1D) Switched to Once Daily (QD) Insulin Glargine (Gla) 300 U/mL (Gla-300): The European REALI Pooled Database.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-724-P
- By:
- Publication type:
- Article
1220-P: Sotagliflozin Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA<sub>1c</sub> Level at 52 Weeks in Adults with T1D.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1220-P
- By:
- Publication type:
- Article
2328-PUB: Identification by Multivariable Analysis of Predictive Factors of HbA1c Target Achievement in People with T2D Initiating Treatment with Insulin Glargine 300 U/mL (Gla-300)—REALI Pooled Database.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2328-PUB
- By:
- Publication type:
- Article
2323-PUB: Predictive Factors of Clinically Important HbA1c Improvement in People with T2DM Initiating Treatment with Insulin Glargine 300 U/mL (Gla-300)—Multivariable Analysis from REALI Pooled Database.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-2323-PUB
- By:
- Publication type:
- Article
1109-P: Type 2 Diabetes Treatment in Patients with Chronic Kidney Disease: Efficacy and Safety of Initiating Insulin Glargine 300 U/mL—REALI Pooled Data Analysis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1109-P
- By:
- Publication type:
- Article
1097-P: Glycemic Control and Safety Profile of Insulin Glargine 300 U/mL in Older Adults—REALI Pooled Data Analysis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-1097-P
- By:
- Publication type:
- Article
Reduced Hypoglycemia Risk in Type 2 Diabetes Patients Switched to/Initiating Insulin Glargine 300 vs 100 U/ml: A European Real-World Study.
- Published in:
- Advances in Therapy, 2020, v. 37, n. 9, p. 3863, doi. 10.1007/s12325-020-01436-5
- By:
- Publication type:
- Article
Safety of Human Insulin in Poor-Sighted Elderly Diabetic Patients.
- Published in:
- Diabetes Care, 1999, v. 22, n. 12, p. 2089, doi. 10.2337/diacare.22.12.2089b
- By:
- Publication type:
- Article
Transferring aged type 1 diabetic patients from animal to human insulin. A randomized study. Investigators of the TRANSFERT Study.
- Published in:
- 1998
- By:
- Publication type:
- clinical trial
Characterizing Short Stature by Insulin-like Growth Factor Axis Status and Genetic Associations: Results From the Prospective, Cross-sectional, Epidemiogenetic EPIGROW Study.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
Somatostatin receptors in resected hepatocellular carcinoma: status and correlation with markers of poor prognosis.
- Published in:
- Histopathology, 2017, v. 70, n. 3, p. 492, doi. 10.1111/his.13034
- By:
- Publication type:
- Article
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article